[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@mikeaxolotl Avatar @mikeaxolotl 🅰️rchangel Mikael

🅰️rchangel Mikael posts on X about $qure, fartcoin, spacex, $asts the most. They currently have XXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours.

Engagements: XXXXX #

Engagements Line Chart

Mentions: X #

Mentions Line Chart

Followers: XXX #

Followers Line Chart

CreatorRank: XXXXXXX #

CreatorRank Line Chart

Social Influence #

Social category influence cryptocurrencies stocks finance currencies

Social topic influence $qure #1, fartcoin, spacex, $asts, over the, $ntla, $prme, bitcoin, $85114b, novartis

Top assets mentioned uniQure N.V. (QURE) Fartcoin (FARTCOIN) AST SpaceMobile, Inc. Class A Common Stock (ASTS) Intellia Therapeutics, Inc (NTLA) Bitcoin (BTC) Novartis AG (NVS)

Top Social Posts #

Top posts by engagements in the last XX hours

"@endless_frank Thats what they get for being 20x leveraged on dogshit2 and fartcoin"
X Link @mikeaxolotl 2025-10-12T01:18Z XXX followers, XXX engagements

"@VladSaigau I hope they just turn into the microstrategy of SpaceX stock. What do you think they plan to do with all this new cash"
X Link @mikeaxolotl 2025-10-13T00:43Z XXX followers, XX engagements

"$ASTS Scotia price downgrade just moments after ASTS announces dilution"
X Link @mikeaxolotl 2025-10-07T13:30Z XXX followers, XXX engagements

"Over the next few months I'm going to be building a small moon-shot portfolio 20K AUD with about XX positions The companies I believe have 10x and greater potential between a 5-10 year timeframe but carry high execution funding and other associated risks at this point in their lifespan. The plan is to set and forget (somewhat). I'll be posting each new position along with some rudimentary research notes as I add them and will give whole portfolio updates bi-annually or when I feel like it. If you have any interesting names you think I should look into what fit this criteria let me know"
X Link @mikeaxolotl 2025-10-13T12:56Z XXX followers, XXX engagements

"@techinvestoor $QURE will get bought out in 6-18 months and it will beat both $NTLA and $PRME from an opportunity cost perspective"
X Link @mikeaxolotl 2025-10-09T19:02Z XXX followers, XXX engagements

"@rationalaussie How are you opting out with bitcoin when the government also taxes gains on bitcoin "Store of wealth" my ass its the first thing to go liquid the moment things start heating up. Just buy precious metals if you want to preserve wealth"
X Link @mikeaxolotl 2025-10-13T15:43Z XXX followers, XXX engagements

"Thesis: $QURE will be acquired for $8.5-11.4B+ within 6-18 months. That's 138-200%+ upside from current levels. Gene therapy companies don't stay independent long after pivotal data. The sector has a 5-year M&A track record showing consistent 88-215% premiums for CNS assets with breakthrough results especially in the 6-18 month pre-approval window. Here's what Novartis Roche Astellas and Biogen have paid for comparable assets and where $QURE sits in the cycle: Novartis / AveXis (2018 Zolgensma) 💰 $8.7B +88% Premium 🧪 Stage: X months pre-BLA (Phase X complete) 📈 Peak Sales: $XX B (2024"
X Link @mikeaxolotl 2025-10-11T15:00Z XXX followers, 41.4K engagements